The technology I’m talking about is three-dimensional cellular construction, better known as 3D bioprinting, and the company delivering this revolutionary technology is Organovo (ONVO).
Based in San Diego, and founded in 2007, Organovo is a startup that looks to take regenerative medicine to the next level with its bioprinting technology.
How It Works
Organovo has created the NovoGen MMX Bioprinter™, the only commercial bioprinter in the world proven to create tissue.
Using both a software and hardware platform, NovoGen can take primary or other human cells and form them into three-dimensional tissue.
Read more and watch video: http://seekingalpha.com/article/428421-organovo-s-3d-bioprinting-a-win-for-pharmaceuticals